Guggenheim Capital LLC Mei Pharma, Inc. Transaction History

Guggenheim Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$1.89 - $4.95 $23,124 - $60,563	-12,235 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.06 - $2.38 $152 - $176	74 Added 0.61%	12,235 $25,000
Q4 2017 Feb 14, 2018	SELL	$1.91 - $2.83 $2,901 - $4,298	-1,519 Reduced 11.1%	12,161 $26,000
Q3 2017 Nov 14, 2017	BUY	$2.44 - $2.91 $33,379 - $39,808	13,680	13,680 $37,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $333M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.